10-Q Filing

CELLDEX THERAPEUTICS, INC. CIK: 744218 Q3 2017

Filing Information

Form Type	10-Q
Accession Number	`0001104659-17-066472`
Period End Date	20170930
Filing Date	20171107
Fiscal Year	2017
Fiscal Period	Q3
XBRL Instance	cldx-20170930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 70 Cash Flow Statement 61

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$72.11M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$42.46M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$54.73M	USD	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$31.74M	USD	Point-in-time
Marketable Securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$147.31M	USD	Point-in-time
Marketable Securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$85.80M	USD	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$1.78M	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$3.01M	USD	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.77M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.01M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	120.52M	shares	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	132.11M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$147.32M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$195.57M	USD	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$13.19M	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	132.11M	shares	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	120.52M	shares	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$11.31M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$81.49M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$67.81M	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$2.00M	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$2.13M	USD	Point-in-time
Goodwill	`Goodwill`	$90.98M	USD	Point-in-time
Goodwill	`Goodwill`	$90.98M	USD	Point-in-time
Total Assets	`Assets`	$383.36M	USD	Point-in-time
Total Assets	`Assets`	$319.42M	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$1.28M	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$1.74M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$17.84M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$28.66M	USD	Point-in-time
Current Portion of Long-Term Liabilities	`OtherLiabilitiesCurrent`	$4.83M	USD	Point-in-time
Current Portion of Long-Term Liabilities	`OtherLiabilitiesCurrent`	$5.79M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$35.22M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$24.91M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$82.70M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$75.35M	USD	Point-in-time
Total Liabilities	`Liabilities`	$117.93M	USD	Point-in-time
Total Liabilities	`Liabilities`	$100.27M	USD	Point-in-time
Commitments and Contingent Liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingent Liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at September 30, 2017 and December 31, 2016	`PreferredStockValue`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at September 30, 2017 and December 31, 2016	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 132,108,478 and 120,516,654 Shares Issued and Outstanding at September 30, 2017 and December 31, 2016, respectively	`CommonStockValue`	$132.00K	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 132,108,478 and 120,516,654 Shares Issued and Outstanding at September 30, 2017 and December 31, 2016, respectively	`CommonStockValue`	$121.00K	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$982.25M	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$1.03B	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.54M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.59M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-808.68M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-719.49M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$219.15M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$265.43M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$319.42M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$383.36M	USD	Point-in-time

Income Statement 70 line items

Line Item	Tag	Value	Unit	Period
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$1.24M	USD	1 Quarter
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$493.00K	USD	1 Quarter
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$1.55M	USD	3 Qtrs
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$2.49M	USD	3 Qtrs
Contracts and Grants	`RevenueFromContractsAndGrants`	$2.69M	USD	1 Quarter
Contracts and Grants	`RevenueFromContractsAndGrants`	$6.80M	USD	3 Qtrs
Contracts and Grants	`RevenueFromContractsAndGrants`	$3.36M	USD	3 Qtrs
Contracts and Grants	`RevenueFromContractsAndGrants`	$1.73M	USD	1 Quarter
Total Revenues	`Revenues`	$9.29M	USD	3 Qtrs
Total Revenues	`Revenues`	$2.22M	USD	1 Quarter
Total Revenues	`Revenues`	$3.92M	USD	1 Quarter
Total Revenues	`Revenues`	$4.91M	USD	3 Qtrs
Research and Development	`ResearchAndDevelopmentExpense`	$72.71M	USD	3 Qtrs
Research and Development	`ResearchAndDevelopmentExpense`	$21.91M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$25.01M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$78.17M	USD	3 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$5.35M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$24.05M	USD	3 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$19.11M	USD	3 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$6.95M	USD	1 Quarter
In-Process Research and Development Impairment	`ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill`	$13.00M	USD	3 Qtrs
In-Process Research and Development Impairment	`ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill`	$13.00M	USD	1 Quarter
Gain on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-4.60M	USD	1 Quarter
Gain on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-200.00K	USD	3 Qtrs
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$254.00K	USD	1 Quarter
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$224.00K	USD	1 Quarter
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$672.00K	USD	3 Qtrs
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$760.00K	USD	3 Qtrs
Total Operating Expenses	`CostsAndExpenses`	$32.21M	USD	1 Quarter
Total Operating Expenses	`CostsAndExpenses`	$102.98M	USD	3 Qtrs
Total Operating Expenses	`CostsAndExpenses`	$105.29M	USD	3 Qtrs
Total Operating Expenses	`CostsAndExpenses`	$35.88M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-96.00M	USD	3 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-98.06M	USD	3 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-29.99M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-31.96M	USD	1 Quarter
Investment and Other Income, Net	`InterestAndOtherIncome`	$1.61M	USD	3 Qtrs
Investment and Other Income, Net	`InterestAndOtherIncome`	$1.84M	USD	3 Qtrs
Investment and Other Income, Net	`InterestAndOtherIncome`	$395.00K	USD	1 Quarter
Investment and Other Income, Net	`InterestAndOtherIncome`	$398.00K	USD	1 Quarter
Net Loss Before Income Tax Benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-31.56M	USD	1 Quarter
Net Loss Before Income Tax Benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-94.39M	USD	3 Qtrs
Net Loss Before Income Tax Benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-96.22M	USD	3 Qtrs
Net Loss Before Income Tax Benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-29.60M	USD	1 Quarter
Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-5.20M	USD	3 Qtrs
Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-5.20M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-96.22M	USD	3 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-89.19M	USD	3 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-29.60M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-26.36M	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.29	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.97	USD	3 Qtrs
Basic and Diluted Net Loss Per Common Share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.20	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.71	USD	3 Qtrs
Shares Used in Calculating Basic and Diluted Net Loss per Share (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	129.64M	shares	1 Quarter
Shares Used in Calculating Basic and Diluted Net Loss per Share (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	125.86M	shares	3 Qtrs
Shares Used in Calculating Basic and Diluted Net Loss per Share (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	100.67M	shares	1 Quarter
Shares Used in Calculating Basic and Diluted Net Loss per Share (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	99.40M	shares	3 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-96.22M	USD	3 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-89.19M	USD	3 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-29.60M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-26.36M	USD	1 Quarter
Unrealized Gain (Loss) on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-113.00K	USD	1 Quarter
Unrealized Gain (Loss) on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$47.00K	USD	3 Qtrs
Unrealized Gain (Loss) on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$11.00K	USD	1 Quarter
Unrealized Gain (Loss) on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$303.00K	USD	3 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-95.92M	USD	3 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-89.14M	USD	3 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-29.71M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-26.35M	USD	1 Quarter

Cash Flow Statement 61 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-96.22M	USD	3 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-89.19M	USD	3 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-29.60M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-26.36M	USD	1 Quarter
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$3.39M	USD	3 Qtrs
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$2.13M	USD	3 Qtrs
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$254.00K	USD	1 Quarter
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$224.00K	USD	1 Quarter
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$672.00K	USD	3 Qtrs
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$760.00K	USD	3 Qtrs
Amortization and Premium of Marketable Securities, Net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-768.00K	USD	3 Qtrs
Amortization and Premium of Marketable Securities, Net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$171.00K	USD	3 Qtrs
Loss on Sale or Disposal of Assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-6.00K	USD	3 Qtrs
Loss on Sale or Disposal of Assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-74.00K	USD	3 Qtrs
In-Process Research and Development Impairment	`ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill`	$13.00M	USD	3 Qtrs
In-Process Research and Development Impairment	`ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill`	$13.00M	USD	1 Quarter
Gain on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-4.60M	USD	1 Quarter
Gain on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-200.00K	USD	3 Qtrs
Income Tax Benefit	`DeferredIncomeTaxExpenseBenefit`	$-5.20M	USD	3 Qtrs
Stock-Based Compensation Expense	`ShareBasedCompensation`	$11.71M	USD	3 Qtrs
Stock-Based Compensation Expense	`ShareBasedCompensation`	$9.73M	USD	3 Qtrs
Non-Cash Expense	`AmortizationOfDebtDiscountPremium`	$1.64M	USD	3 Qtrs
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$609.00K	USD	3 Qtrs
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$1.23M	USD	3 Qtrs
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$325.00K	USD	3 Qtrs
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-525.00K	USD	3 Qtrs
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	$-132.00K	USD	3 Qtrs
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-10.89M	USD	3 Qtrs
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-11.56M	USD	3 Qtrs
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-987.00K	USD	3 Qtrs
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-1.05M	USD	3 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-80.41M	USD	3 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-92.69M	USD	3 Qtrs
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$194.91M	USD	3 Qtrs
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$183.68M	USD	3 Qtrs
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$149.88M	USD	3 Qtrs
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$122.23M	USD	3 Qtrs
Investment in Other	`PaymentsToAcquireOtherInvestments`	$1.80M	USD	3 Qtrs
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.11M	USD	3 Qtrs
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.60M	USD	3 Qtrs
Net Cash Provided by Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$41.12M	USD	3 Qtrs
Net Cash Provided by Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$59.85M	USD	3 Qtrs
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$32.64M	USD	3 Qtrs
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$10.67M	USD	3 Qtrs
Proceeds from Issuance of Stock from Employee Benefit Plans	`ProceedsFromStockPlans`	$192.00K	USD	3 Qtrs
Proceeds from Issuance of Stock from Employee Benefit Plans	`ProceedsFromStockPlans`	$532.00K	USD	3 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$32.83M	USD	3 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$11.20M	USD	3 Qtrs
Net Increase (Decrease) in Cash and Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-40.37M	USD	3 Qtrs
Net Increase (Decrease) in Cash and Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$12.27M	USD	3 Qtrs
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$72.11M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$42.46M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$54.73M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$31.74M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$72.11M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$42.46M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$54.73M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$31.74M	USD	Point-in-time
Acquisition of Property and Equipment Included in Accounts Payable and Accrued Expenses	`CapitalExpendituresIncurredButNotYetPaid`	$75.00K	USD	3 Qtrs
Acquisition of Property and Equipment Included in Accounts Payable and Accrued Expenses	`CapitalExpendituresIncurredButNotYetPaid`	$65.00K	USD	3 Qtrs
Shares Issued to Former Kolltan Executive for Settlement of Severance	`SharesIssuedToFormerKolltanExecutiveForSettlementOfSeverance`	$302.00K	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.